Abstract:Nrf2 is a key transcription factor that regulates redox status by up‐regulating antioxidant genes. Previous data from our laboratory demonstrated that increased ROS in the RVLM contributed to the sympatho‐excitation in rabbits with chronic heart failure. Accordingly, we hypothesized that deletion of Nrf2 in the RVLM of mice will increase sympathetic drive due to oxidative stress by down‐regulating antioxidant protein expression. Twenty seven Nrf2 Floxed mice were randomized into two groups: control mice received Lenti‐GFP microinjection into bilateral RVLM, while Nrf2‐deleted mice received Lenti‐Cre‐GFP. Real‐time RT‐PCR, Western blot analysis, immunofluorescence, DHE staining, and ELISA were used to evaluate mRNA level, protein expression, ROS production, and NE concentration. Blood pressure in the conscious state was measured by the radiotelemetry. Renal sympathetic nerve activity (RSNA) was recorded under anesthesia. We found that (1) Nrf2 mRNA and protein levels in the RVLM of Cre‐mice were significantly lower than GFP‐mice (mRNA: 0.3 ± 0.1 vs 1.0 ± 0.1; protein: 0.07 ± 0.02 vs 0.32 ± 0.03. **P < 0.01, n = 6). The down‐regulated Nrf2 protein in the RVLM of Cre‐mice was further confirmed by immunofluorescence staining, where the Lenti‐Cre‐GFP positive neurons exhibited a markedly decreased Nrf2 protein compared to the adjacent negative neurons. (2) The expression of principle antioxidant proteins targeted by Nrf2, including NQO1, HO1, SOD2, and Catalase, were significantly lower in the RVLM of Cre‐mice (HO1: 0.93 ± 0.10 vs 1.27 ± 0.12; NQO1: 0.57 ± 0.08 vs 0.93 ± 0.12; SOD2: 0.46 ± 0.10 vs 1.68 ± 0.14; Catalase: 0.34 ± 0.13 vs 1.11 ± 0.20; *P < 0.05, n = 6). Consistent with the change in antioxidant protein expression, the superoxide level in the Lenti‐Cre‐GFP positive neurons was significantly increased (arbitrary DHE signal: 71.8 ± 2.95 vs 39.2 ± 0.67; *P < 0.05, n = 10 and 12). (3) In the conscious state, Cre‐mice displayed a significant increase in blood pressure compared to GFP‐mice (24h averaged MAP: 123.7 ± 3.8 vs 100.2 ± 2.2 mm Hg, *p < 0.05, n = 6). In addition, Cre‐mice had significantly elevated urinary NE concentration (456.4 ± 16.9 vs 356.5 ± 19.9 ng/mL, *P < 0.05, n = 13–14) and 24‐hour NE excretion (676.5 ± 64.1 vs 416.5 ± 28.1 ng, *P < 0.05, n = 13–14), and decreased spontaneous baroreflex gain (Up‐sequence: 1.66 ± 0.17 vs 3.61 ± 0.22 ms/mm Hg, *P < 0.05, n = 6; Down‐sequence: 1.89 ± 0.12 vs 2.98 ± 0.19 ms/mmHg, *P < 0.05, n = 6) as compared to GFP‐mice. (4) Under anesthesia, Cre‐mice displayed elevated baseline RSNA (63.75 ± 8.1 vs 24.21 ± 4.3 %/Max, *P < 0.05, n = 5) and impaired inducible baroreflex function (Ave Slope: 0.08 ± 0.01 vs 0.13 ± 0.02 %mmHg; Gain Max: 1.64 ± 0.2 vs 3.46 ± 0.2 %mmHg; Minimum RSNA: 8.98 ± 1.21 vs 46.32 ± 5.51 %/Max; PB50: 122.34 ± 8.9 vs 90.13 ± 11.5 mmHg; Range of RSNA Response: 79.9 ± 9.8 vs 107.4 ± 12.4 %/Max, *P < 0.05, n = 5–6). Based on the above data, we conclude that selective Nrf2 gene deletion in the RVLM elevates blood pressure, increases sympathetic outflow, and impairs baroreflex function potentially by the oxidative stress due to the impaired antioxidant mechanisms. Supported by NIH grant P01‐HL62222

Abstract 088: Overexpression of Neuronal Nitric Oxide Synthase Associated Protein in the Paraventricular Nucleus Contributes to Increased Sympathoexcitation in Male Mice by Modulating Subcellular Localization of Neuronal Nitric Oxide Synthase

Neuronal Nitric Oxide Synthase Associated Protein: Nos1ap Mediates Sympathoexcitation Through Paraventricular Nucleus of the Hypothalamus

Excessive Penile Norepinephrine Level Underlies Impaired Erectile Function in Adenosine A1 Receptor Deficient Mice

Abstract 085: Loss of Microglia Enhances Neuronal Activity in the Sympathetic Paraventricular Nucleus

Neuronal and Endothelial Nitric Oxide Synthases in the Paraventricular Nucleus Modulate Sympathetic Overdrive in Insulin-Resistant Rats

Downregulation of Neuronal Nitric Oxide Synthase (nnos) Within the Paraventricular Nucleus in Ins2akita-Type-1 Diabetic Mice Contributes to Sympatho-Excitation

Generation of a cre recombinase-conditional Nos1ap over-expression transgenic mouse

Gene Transfer of Neuronal Nitric Oxide Synthase to Carotid Body Reverses Enhanced Chemoreceptor Function in Heart Failure Rabbits

ROS and Endothelial Nitric Oxide Synthase (Enos)-Dependent Trafficking of Angiotensin II Type 2 Receptor Begets Neuronal NOS in Cardiac Myocytes.

Nos1+ and Nos1− excitatory neurons in the BLA regulate anxiety- and depression-related behaviors oppositely

Abstract P200: Role of Macula Densa Neuronal Nitric Oxide Synthase in Control of Renin Release and Blood Pressure Recovery Following Hemorrhagic Shock

Neuronal Nitric Oxide Synthase is Up-Regulated by Angiotensin II and Attenuates NADPH Oxidase Activity and Facilitates Relaxation in Murine Left Ventricular Myocytes

Selective Nrf2 Gene Deletion in the RVLM Increases Blood Pressure and Evokes Sympatho‐Excitation in Mice

Selective Nrf2 Gene Deletion in the Rostral Ventrolateral Medulla Evokes Hypertension and Sympathoexcitation in Mice.

Orexin A Increases Sympathetic Nerve Activity Through Promoting Expression of Proinflammatory Cytokines in Sprague Dawley Rats

Expression of Neuronal Nitric Oxide Synthase in Rabbit Carotid Body Glomus Cells Regulates Large-Conductance Ca2+-Activated Potassium Currents

Inhibition of Nitric Oxide Synthase 1 Induces Salt-Sensitive Hypertension in Nitric Oxide Synthase 1α Knockout and Wild-Type Mice

Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals

Pancreatic Specific Deletion of NOS1AP Lowered Islet Mass

Unexpected Heterodivalent Recruitment of NOS1AP to Nnos Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models

Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (angiotensin II)